how does crypto investing work- Top Related searches

The governor of the Swiss National Bank once again threatened negative interest rates, saying that it really worked. Martin Schlegel, governor of the Swiss National Bank, said that the bank did not like negative interest rates, but would use them again when necessary to curb speculation in the Swiss franc. Before his speech, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. The new central bank governor once again threatened to re-implement the negative interest rate policy if necessary. "Nobody likes negative interest rates, and neither does the Swiss National Bank," Schlegel told Bloomberg Television in Bern. "Of course, we will also be ready to implement negative interest rates again if necessary. But as we cut interest rates today, the possibility of negative interest rates has been reduced. "CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.

The number of employed people in Australia increased by 35,613 in November, and it is estimated to be 25,000.Polish Prime Minister: There is no plan to send troops to Ukraine after the ceasefire between Russia and Ukraine. On December 12, local time, Polish Prime Minister Tusk said after meeting with French President Macron that the decision on whether to send troops to Ukraine after the ceasefire between Russia and Ukraine will be made by Poland itself. At present, Poland has no such plan. In addition, Baussac, deputy speaker of the Polish House of Representatives, said at a news conference that sending troops to Ukraine was not in the interests of Poland, the EU and NATO. He expressed firm opposition to this. Baussac said that the Polish government should clearly and directly state its position and refuse to send troops to Ukraine. Polish Prime Minister Tusk said on the 10th that peace talks on the Russian-Ukrainian conflict may start this winter. Tusk said at the government meeting that Poland will take over the rotating presidency of the European Union in January next year, when Poland will play an important role in the negotiations on the Russian-Ukrainian conflict. He said that peace talks may start this winter, and Poland will participate in the arrangement of the political agenda and even lead the development of the situation during the negotiations. (CCTV News)Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.

CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.Australia's unemployment rate in November was 3.93%, which is estimated to be 4.2%.According to Siemens, digital business revenue has more than doubled this year, reaching 1.7 billion euros, exceeding the commitment in 2021 ahead of schedule.